Thus, in addition to being a prognostic factor, the TP53 mutation profile may influence the effectiveness of chemotherapy and hormonal therapy, which are used to treat breast cancer and are therefore examined before administration of such treatments [41,43,44,45]. This evidence concerns the gene TP53 and breast cancer.